FLT3 and acute myeloid leukemia: Some of the most frequent aberrations occurring—such as FMS-like tyrosine kinase 3 (FLT3), a major driver of oncogenic signaling in AML and one of the main prognostic markers—finely regulate cell proliferation, differentiation and survival, thus indirectly acting also on the modulation of energy metabolism [66].